CompletedNot Applicable

Prospective Analysis of Septic Associated Encephalopathy Using the Non-invasive Acoustocerebrography-ACG

Germany20 participantsStarted 2016-06-01

Plain-language summary

The patients of the group "sepsis" are measured several times with the non-invasive multi-spectral sonography (Sonovum "ACG-Diagnosesystem") (days 1, 3, 7 and 14). The patients of the group "control" are measured on days 1 and 3 with the system. A measurement takes 3 minutes. For this purpose two ultrasound heads are placed above the patient's ears and fixed with an all-head harness. The device is certified for CE application. There are no known health risks of ultrasound in humans.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Severe sepsis or septic shock * Clinical suspicion of septic encephalopathy * consent to the study by the patient or legal representative * stay in intensive care unit for at least 24 hours without the presence of a septic disease and without clinical guidance for an SE Exclusion Criteria: * Inability to consent to participation in the research project or rejection by patients or legal representatives * existence of other causes of delir other than sepsis (e.g., withdrawal) * Infrequent prognosis (expected death in ≤ 12 hours despite maximum therapy)

What they're measuring

Principal Components analysis vs ICDSC (Intensive Care Delirium Screening Checklist)-Score

Timeframe: Day 1

Principal Components analysis vs ICDSC / SOFA (Sepsis-related Organ Failure Assessment Score)-Score

Timeframe: Day 1

Trial details

NCT IDNCT03173196

SponsorUniversity of Rostock

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-07-10

View on ClinicalTrials.gov More Encephalopathy trials